These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7816309)

  • 1. Response to alpha 2B interferon (IFN) treatment in a haemodialysis patient with chronic hepatitis C.
    Barril G; Schez Tomero JA; Garcia Buey L; Motellon JL; Bernis C; Traver JA
    Nephrol Dial Transplant; 1994; 9(9):1354-5. PubMed ID: 7816309
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon-alpha 2b treatment of chronic hepatitis C in haemodialysis patients.
    Raptopoulou-Gigi M; Spaia S; Garifallos A; Xenou P; Orphanou H; Zarafidou E; Petridou P; Vrettou H; Vagionas G; Galaktidou G
    Nephrol Dial Transplant; 1995 Oct; 10(10):1834-7. PubMed ID: 8592590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-alpha is effective in the treatment of chronic hepatitis C.
    Worman HJ
    Am J Gastroenterol; 1995 Apr; 90(4):679-80. PubMed ID: 7717348
    [No Abstract]   [Full Text] [Related]  

  • 4. Interferon-alpha treatment of haemodialysis patients with chronic viral hepatitis and its impact on kidney transplantation.
    Simsek H
    Nephrol Dial Transplant; 1996 May; 11(5):912-3. PubMed ID: 8671933
    [No Abstract]   [Full Text] [Related]  

  • 5. A randomized controlled trial of interferon-alpha in patients with cirrhosis caused by 2a/2b genotype hepatitis C virus.
    Ikeda K; Kumada H; Saitoh S; Suzuki Y; Kobayashi M; Tsubota A; Koida I; Fukuda M; Arase Y; Chayama K; Murashima N; Tango T
    J Hepatol; 1998 May; 28(5):910-1. PubMed ID: 9625329
    [No Abstract]   [Full Text] [Related]  

  • 6. [Autoimmune hepatitis type 1 revealed during treatment with interferon].
    Tran A; Beusnel C; Montoya ML; Lussiez V; Hébuterne X; Rampal P
    Gastroenterol Clin Biol; 1992; 16(8-9):722-3. PubMed ID: 1426834
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationships between plasma ferritin and aminotransferase profile in haemodialysis patients with hepatitis C virus.
    Caramelo C; Albalate M; Bermejillo T; Navas S; Ortiz A; de Sequera P; Casado S; Carreño V
    Nephrol Dial Transplant; 1996 Sep; 11(9):1792-6. PubMed ID: 8918624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of ketoprofen and interferon combination therapy to improve interferon-resistant chronic hepatitis C.
    Anderson FH; Zeng L; Yoshida EM; Rock NR
    Can J Gastroenterol; 1997; 11(4):294-7. PubMed ID: 9218853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon may be useful in hemodialysis patients with hepatitis C virus chronic infection who are candidates for kidney transplant.
    Casanovas Taltavull T; Baliellas C; Sesé E; Iborra MJ; Benasco C; Andrés E; González MT; Gil-Vernet S; Casanova A; Casais LA
    Transplant Proc; 1995 Aug; 27(4):2229-30. PubMed ID: 7652784
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of chronic hepatitis C with recombinant interferon alpha 2b.
    Terranova R; Luca S
    J Chemother; 1992 Oct; 4(5):297-302. PubMed ID: 1479419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of chronic hepatitis C with recombinant alpha 2b interferon in kidney transplant recipients: preliminary results and side effects.
    Rostaing L; Izopet J; Baron E; Duffaut M; Puel J; Durand D
    Transplant Proc; 1995 Feb; 27(1):948-50. PubMed ID: 7879242
    [No Abstract]   [Full Text] [Related]  

  • 12. Interferon treatment of chronic active hepatitis C in patients with end-stage chronic renal failure.
    Ozyilkan E; Simşek H; Uzunalimoğlu B; Telatar H
    Nephron; 1995; 71(2):156-9. PubMed ID: 8569947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response related factors in recombinant interferon alfa-2b treatment of chronic hepatitis C.
    Pérez R; Pravia R; Linares A; Rodríguez M; Lombraña JL; Suárez A; Riestra S; Navascués CA; Rodrigo L
    Gut; 1993; 34(2 Suppl):S139-40. PubMed ID: 8314482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term interferon alfa-2b retreatment of relapsing patients with chronic hepatitis C.
    Picciotto A; Sinelli N; Brizzolara R; Campo N; Lapertosa G; Celle G
    J Hepatol; 1997 Feb; 26(2):447-8. PubMed ID: 9059973
    [No Abstract]   [Full Text] [Related]  

  • 15. Breakthrough during recombinant interferon alfa therapy in patients with chronic hepatitis C virus infection: prevalence, etiology, and management.
    Roffi L; Mels GC; Antonelli G; Bellati G; Panizzuti F; Piperno A; Pozzi M; Ravizza D; Angeli G; Dianzani F
    Hepatology; 1995 Mar; 21(3):645-9. PubMed ID: 7875661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicentre randomised controlled trial of recombinant interferon alfa-2b in patients with acute non-A, non-B/type C hepatitis after transfusion.
    Colombo M; Lampertico P; Rumi M
    Gut; 1993; 34(2 Suppl):S141. PubMed ID: 8314483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover.
    Zeuzem S; Schmidt JM; Lee JH; von Wagner M; Teuber G; Roth WK
    Hepatology; 1998 Jul; 28(1):245-52. PubMed ID: 9657119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of chronic hepatitis C with recombinant interferon alfa.
    Chen YK; Bala K
    West J Med; 1992 Jan; 156(1):72. PubMed ID: 1734608
    [No Abstract]   [Full Text] [Related]  

  • 19. Interferon-alpha treatment for severe atopic dermatitis.
    Kimata H; Akiyama Y; Kubota M; Furusho K
    Allergy; 1995 Oct; 50(10):837-40. PubMed ID: 8607568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dialysis hemosiderosis mimicking non-A, non-B hepatitis.
    Stanbaugh GH; Gillit DM; Holmes AW
    Trans Am Soc Artif Intern Organs; 1984; 30():217-21. PubMed ID: 6442805
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.